Recent Company News

• 12:07 AM ET Feb 12, 2026
  

  StreetAccount Consensus Metrics Preview - Olympus Q3 Earnings (¥1956.0000, -19)

• 06:25 PM ET Jan 13, 2026
  

  Transcript Intelligence: Olympus at J.P. Morgan Healthcare Conference (¥2072.0000, 0)

• 04:07 PM ET Dec 05, 2025
  

  Olympus announces voluntary corrective action for PolyLoop single-use ligating device (¥2027.5000, 0)

• 08:21 AM ET Dec 05, 2025
  

  Olympus, Gore, and ConMed announce transition of commercial support for the Gore VIABIL Biliary Endoprosthesis in the US (¥2027.5000, 0)

• 09:34 PM ET Nov 09, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 08:23 PM ET Nov 09, 2025
  

  StreetAccount Asia Macro Headlines:

• 08:03 PM ET Nov 09, 2025
  

  Quick Take - Olympus trading +11.0% following solid Q2 results; mid-term plan cautious (¥2083.5000, +212)

• 02:02 AM ET Nov 07, 2025
  

  Olympus expects to layoff ~2K positions across company through organization simplification (¥1871.5000, 0)

• 01:50 AM ET Nov 07, 2025
  

  Olympus three-year financial plan: targets FY27-29 EPS CAGR (adjusted for extraordinary items) of more than 10% from FY26 (¥1871.5000, 0)

• 01:46 AM ET Nov 07, 2025
  

  StreetAccount Metrics Recap - Olympus Q2 Earnings (¥1871.5000, 0)